文献速递关节外科创伤骨科

全髋与全膝关节置换术后清创、抗生素及假体保留的疗效:系统综述与Meta分析

Efficacy of Debridement, Antibiotics, and Implant Retention in Total Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis.
PubMed 文献 · J Arthroplasty · 2025-06-04

该系统综述与Meta分析检索2013至2023年MEDLINE、Scopus、Web of Science及参考文献,纳入81项提供DAIR治疗髋或膝假体周围感染结局定量数据的研究。DAIR总失败率为35.9%(95%CI 23.9-48.0),急性/早期术后感染为34.2%(95%CI 28.8-39.6),急性血源性感染为39.1%,晚期慢性感染为73.6%。作者认为DAIR是治疗假体周围感染的可行选择,失败率可接受,尤其对急性假体周围感染。

要点

  • DAIR总失败率为35.9%(95%CI 23.9-48.0)。
  • 急性/早期术后感染失败率为34.2%(95%CI 28.8-39.6)。
  • 晚期慢性感染失败率高达73.6%。

核心结论

  • DAIR是治疗假体周围感染的可行选择,失败率可接受,尤其对急性假体周围感染。
  • 该系统综述提供有助于优化患者选择和假体周围感染治疗方案的变量信息。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、Scopus、Web of Science及2013至2023年相关研究的参考文献。
  • 纳入81项提供DAIR治疗髋或膝假体周围感染结局定量数据的研究,采用随机效应模型进行Meta分析。

主要发现

  • DAIR失败率范围为0至84.4%,总体合并估计值为35.9%(95%CI 23.9-48.0)。
  • 急性/早期术后感染失败率为34.2%(95%CI 28.8-39.6),急性血源性感染为39.1%,晚期慢性感染为73.6%。
  • 按关节类型分层,膝关节置换术失败率高于髋关节。
  • 金黄色葡萄球菌是与DAIR失败相关的最常见微生物。
  • 糖尿病和心血管疾病是这些患者中常见的合并症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Periprosthetic joint infection (PJI) remains a challenging complication in total joint arthroplasty, often leading to the necessity of revision surgery. The treatment strategy of debridement, antibiotics, and implant retention (DAIR) is widely used for the management of acute PJI, with variable success rates across studies. We aimed to examine the effectiveness of DAIR in the management of PJI after primary hip and knee arthroplasties. METHODS: We searched MEDLINE, Scopus, Web of Science, and reference lists of relevant studies from 2013 to 2023. Studies that provided quantitative data on the outcomes of DAIR for hip or knee PJIs were included. The primary outcome was the failure rate of DAIR. The secondary outcome included failure rates by joint type (hip or knee). The study used a random effects model for meta-analysis. RESULTS: The search generated 572 studies, of which 81 studies were included. The failure rate for DAIR ranged from 0 to 84.4%, with an overall pooled estimate of 35.9% (95% confidence interval [CI]: 23.9 to 48.0). Further analysis revealed remarkable variation in failure rates depending on the timing of the infection: 34.2% (95% CI: 28.8 to 39.6) for acute/early postoperative infections, 39.1% for acute hematogenous infections, and 73.6% for late chronic infections. The failure rates were also stratified by joint type, revealing higher failure rates in knee arthroplasties compared to hip. Staphylococcus aureus was the most common microorganism linked to DAIR failure. Diabetes mellitus and cardiovascular disease were the prevalent comorbidities in these patients. CONCLUSIONS: These findings highlight that the DAIR approach is a viable option for the treatment of PJI, with acceptable failure rates, especially for acute PJI. Furthermore, this systematic review provides insights into variables that can aid in refining patient selection and treatment protocols for managing PJI.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Abbaszadeh A, Yilmaz MK, Izadi N, et al. Efficacy of Debridement, Antibiotics, and Implant Retention in Total Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis. J Arthroplasty. 2025. PMID: 40480337. doi:10.1016/j.arth.2025.05.121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。